Induction of apoptosis by D-limonene is mediated by inactivation of Akt in LS174T human colon cancer cells

Oncology Reports

Volumn 29, Issue 1, 2013, Pages 349-354

  Jia, Shu Sheng ^a   Xi, Guang Peng ^a   Zhang, Ming ^a   Chen, Yan Bo ^a   Lei, Bo ^a   Dong, Xin Shu ^a   Yang, Yan Mei ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Akt; Apoptosis; D limonene

Indexed keywords

CASPASE 3; CASPASE 9; CYTOCHROME C; GLYCOGEN SYNTHASE KINASE 3BETA; LIMONENE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; SERINE; THREONINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL DEATH; CELL VIABILITY; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN CLEAVAGE;

ANTICARCINOGENIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CASPASE 3; CELL PROLIFERATION; COLONIC NEOPLASMS; CYCLOHEXENES; CYTOCHROMES C; CYTOSOL; FLOW CYTOMETRY; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MITOCHONDRIA; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; TERPENES; TUMOR CELLS, CULTURED;

EID: 84872873809     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2093     Document Type: Article

References (38)

1. Sun J: D-Limonene: safety and clinical applications. Altern Med Rev 12: 259-264, 2007.
2. Hakim IA, Harris RB and Ritenbaugh C: Citrus peel use is associated with reduced risk of squamous cell carcinoma of the skin. Nutr Cancer 37: 161-168, 2000.
3. Maltzman TH, Hurt LM, Elson CE, Tanner MA and Gould MN: The prevention of nitrosomethylurea-induced mammary tumors by d-limonene and orange oil. Carcinogenesis 10: 781-783, 1989.
4. Elson CE, Maltzman TH, Boston JL, Tanner MA and Gould MN: Anti-carcinogenic activity of d-limonene during the initiation and promotion/progression stages of DMBA-induced rat mammary carcinogenesis. Carcinogenesis 9: 331-332, 1988.
5. Uedo N, Tatsuta M, Iishi H, et al: Inhibition by D-limonene of gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats. Cancer Lett 137: 131-136, 1999.
6. Giri RK, Parija T and Das BR: d-limonene chemoprevention of hepatocarcinogenesis in AKR mice: Inhibition of c-jun and c-myc. Oncol Rep 6: 1123-1127, 1999.
7. Nakaizumi A, Baba M, Uehara H, Iishi H and Tatsuta M: d-Limonene inhibits N-nitrosobis(2-oxopropyl)amine induced hamster pancreatic carcinogenesis. Cancer Lett 117: 99-103, 1997.
8. Wattenberg LW, Sparnins VL and Barany G: Inhibition of N-nitrosodiethylamine carcinogenesis in mice by naturally occurring organosulfur compounds and monoterpenes. Cancer Res 49: 2689-2692, 1989.
9. Vigushin DM, Poon GK, Boddy A, et al: Phase I and pharmacokinetic study of D-limonene in patients with advanced cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee. Cancer Chemother Pharmacol 42: 111-117, 1998.
10. Steele VE, Kelloff GJ, Wilkinson BP and Arnold JT: Inhibition of transformation in cultured rat tracheal epithelial cells by potential chemopreventive agents. Cancer Res 50: 2068-2074, 1990.
11. Maltzman TH, Christou M, Gould MN and Jefcoate CR: Effects of monoterpenoids on in vivo DMBA-DNA adduct formation and on phase I hepatic metabolizing enzymes. Carcinogenesis 12: 2081-2087, 1991.
12. Van der Logt EM, Roelofs HM, van Lieshout EM, Nagengast FM and Peters WH: Effects of dietary anticarcinogens and nonsteroidal anti-inflammatory drugs on rat gastrointestinal UDP-glucuronosyltransferases. Anticancer Res 24: 843-849, 2004.
13. Manuele MG, Barreiro Arcos ML, Davicino R, Ferraro G, Cremaschi G and Anesini C: Limonene exerts antiproliferative effects and increases nitric oxide levels on a lymphoma cell line by dual mechanism of the ERK pathway: relationship with oxidative stress. Cancer Invest 28: 135-145, 2010.
14. Lu XG, Zhan LB, Feng BA, Qu MY, Yu LH and Xie JH: Inhibition of growth and metastasis of human gastric cancer implanted in nude mice by d-limonene. World J Gastroenterol 10: 2140-2144, 2004.
15. Hata T, Sakaguchi I, Mori M, et al: Induction of apoptosis by Citrus paradisi essential oil in human leukemic (HL-60) cells. In Vivo 17: 553-559, 2003.
16. Ji J, Zhang L, Wu YY, Zhu XY, Lv SQ and Sun XZ: Induction of apoptosis by d-limonene is mediated by a caspase-dependent mitochondrial death pathway in human leukemia cells. Leuk Lymphoma 47: 2617-2624, 2006.
17. Franke TF, Hornik CP, Segev L, Shostak GA and Sugimoto C: PI3K/Akt and apoptosis: size matters. Oncogene 22: 8983-8998, 2003.
18. Bader AG, Kang S, Zhao L and Vogt PK: Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer 5: 921-929, 2005.
19. Niedermeier M, Hennessy BT, Knight ZA, et al: Isoform-selective phosphoinositide 3'-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach. Blood 113: 5549-5557, 2009.
20. Cui B, Tao J and Yang Y: Studies on the expression patterns of class I PI3K catalytic subunits and its prognostic significance in colorectal cancer. Cell Biochem Biophys 62: 47-54, 2012.
21. Page C, Lin HJ, Jin Y, et al: Overexpression of Akt/AKT can modulate chemotherapy-induced apoptosis. Anticancer Res 20: 407-416, 2000.
22. Opel D, Naumann I, Schneider M, Bertele D, Debatin KM and Fulda S: Targeting aberrant PI3K/Akt activation by PI103 restores sensitivity to TRAIL-induced apoptosis in neuroblastoma. Clin Cancer Res 17: 3233-3247, 2011.
23. Garcia-Echeverria C and Sellers WR: Drug discovery approaches targeting the PI3K/Akt pathway in cancer. Oncogene 27: 5511-5526, 2008.
24. Crowder RJ and Freeman RS: Glycogen synthase kinase-3 beta activity is critical for neuronal death caused by inhibiting phosphatidylinositol 3-kinase or Akt but not for death caused by nerve growth factor withdrawal. J Biol Chem 275: 34266-34271, 2000.
25. Szanto A, Bognar Z, Szigeti A, Szabo A, Farkas L and Gallyas F Jr.: Critical role of bad phosphorylation by Akt in cytostatic resistance of human bladder cancer cells. Anticancer Res 29: 159-164, 2009.
26. Cardone MH, Roy N, Stennicke HR, et al: Regulation of cell death protease caspase-9 by phosphorylation. Science 282: 1318-1321, 1998.
27. Kim SH, Park EJ, Lee CR, et al: Geraniol induces cooperative interaction of apoptosis and autophagy to elicit cell death in PC-3 prostate cancer cells. Int J Oncol 40: 1683-1690, 2012.
28. Chaudhary SC, Siddiqui MS, Athar M and Alam MS: D-Limonene modulates inflammation, oxidative stress and Ras-ERK pathway to inhibit murine skin tumorigenesis. Hum Exp Toxicol 31: 798-811, 2012.
29. Kaji I, Tatsuta M, Iishi H, Baba M, Inoue A and Kasugai H: Inhibition by d-limonene of experimental hepatocarcinogenesis in Sprague-Dawley rats does not involve p21(ras) plasma membrane association. Int J Cancer 93: 441-444, 2001.
30. Rabi T and Bishayee A: d-Limonene sensitizes docetaxel-induced cytotoxicity in human prostate cancer cells: Generation of reactive oxygen species and induction of apoptosis. J Carcinog 8: 9, 2009.
31. Khan N, Adhami VM and Mukhtar H: Apoptosis by dietary agents for prevention and treatment of cancer. Biochem Pharmacol 76: 1333-1339, 2008.
32. Hsieh CC, Hernandez-Ledesma B and de Lumen BO: Lunasin, a novel seed peptide, sensitizes human breast cancer MDA-MB-231 cells to aspirin-arrested cell cycle and induced apoptosis. Chem Biol Interact 186: 127-134, 2010.
33. Sun SY, Hail N Jr. and Lotan R: Apoptosis as a novel target for cancer chemoprevention. J Natl Cancer Inst 96: 662-672, 2004.
34. Baysan A, Yel L, Gollapudi S, Su H and Gupta S: Arsenic trioxide induces apoptosis via the mitochondrial pathway by upregulating the expression of Bax and Bim in human B cells. Int J Oncol 30: 313-318, 2007.
35. Uren RT, Dewson G, Chen L, et al: Mitochondrial permeabilization relies on BH3 ligands engaging multiple prosurvival Bcl-2 relatives, not Bak. J Cell Biol 177: 277-287, 2007.
36. Chen M, Guerrero AD, Huang L, et al: Caspase-9-induced mitochondrial disruption through cleavage of anti-apoptotic BCL-2 family members. J Biol Chem 282: 33888-33895, 2007.
37. Krystal GW, Sulanke G and Litz J: Inhibition of phosphatidylinositol 3-kinase-Akt signaling blocks growth, promotes apoptosis, and enhances sensitivity of small cell lung cancer cells to chemotherapy. Mol Cancer Ther 1: 913-922, 2002.
38. Liu X, Shi Y, Giranda VL and Luo Y: Inhibition of the phosphatidylinositol 3-kinase/Akt pathway sensitizes MDA-MB468 human breast cancer cells to cerulenin-induced apoptosis. Mol Cancer Ther 5: 494-501, 2006.